Backgrounds/Aims: The aim of this study is to analyze surgical outcomes and prognostic factors affecting survival after surgical resection in patients with gallbladder cancer. Methods: We retrospectively reviewed 86 patients treated surgically for gallbladder cancer from January 2000 to December 2009 at Chonbuk National University Hospital. Clinicopathologic factors, surgical treatment and outcome data were analyzed. Results: Among the 86 patients (44 male, 42 female) with gallbladder cancer, the mean age was 62.9 years (range: 32-80) and the median survival was 42.4±3.5 month. The overall cumulative survival rates of 86 patients were for 1 year, 83.7%; 3 year, 67.4%; 5 year survival, 61.7%. Univariate analysis revealed that preoperative serum alanine aminotransferase, alkaline phosphatase, total bilirubin, carcinoembryonic antigen (CEA), T staging, N staging were statistically significantly associated with survival. CEA (p=0.004) and T staging (p=0.005) were associated with survival in multivariate analysis. Two-year survival rates were analyzed according to the methods of surgical resection, with simple cholecystectomy showing 100%, whereas extended cholecystectomy showed about 83% in T1b. We could not find out any adverse effect of the simple cholecystectomy for survival. Conclusions: CEA and T stage are independent significant prognostic factor associated with patient survival in our study. Simple cholecystectomy can be regarded as curative resection in stage T1b. Longer observation periods and more cases will be needed to confirm these conclusions. 
INTRODUCTION
Gallbladder cancer is the most common cancer of the biliary tract. According to the Korea Central Cancer Registry report in 2008, gallbladder cancer is the fifth most frequent cancer in the gastrointestinal tract. 1 Early detection of gallbladder cancer is difficult due to asymptomatic growth. Many patients have infiltration of surrounding structures such as the portal vein and hepatic artery at time of diagnosis. Therefore gallbladder cancer has the shortest median survival duration in biliary cancers. 2, 3 Five-year survival rate has been reported as 17.3%. 1 However, recent studies show improved survival rates, attributable to early detection through the development of pre-operative radiologic diagnostic tools, increased awareness of personal health and spread of routine health checkups, as well as improved surgical methods and post operative care.
The aim of this study is to analyze surgical outcomes and prognostic factors affecting survival after surgical resection in patients with gallbladder cancer at our institution.
METHODS
We (Table 1) . (Fig. 2) .
Survival rates according to T stage and N stage

Prognostic factors
ALT, ALP, T-bil and CEA, T and N stage were significant factors on univariate analysis.
Of these factors, CEA and T stage were statistically significant independent prognostic factors on multivariate analysis ( Table 2) .
Survival rates according to surgical method in T stage
Of the 86 cases, 60 cases underwent curative resection, while 26 cases were operated palliatively. In the curative resection groups, the survival rates were 1-year (90.0%), (Fig. 4) .
DISCUSSION
Despite increased early detection through the development of preoperative diagnostic tools, greater acceptance of routine health checkups, and increased survival rate through advanced operative procedures and post-operative care, gallbladder cancer still has a poor prognosis, especially since many patients are inoperable at diagnosis. 3, 4 In a study of 724 cases carried out by the French Surgical Association in 1994, the median survival period was 3 months, and 5 year survival rates were 5%. 5 Konstantinidis et al. 6 reported a 40-year follow-up study which showed medial survival of 3. Various clinical prognostic factors in gallbladder cancer have been reported. Generally, incidence is 2 to 6 times higher in women, which is probably due to the fact that cholelithiasis is more frequent in women. Despite the lower incidence rate, male gender is a poor prognostic factor, showing shorter medial survival periods. 2, 8 There was no survival difference according to gender in our study.
There are no characteristic symptoms in early gallbladder cancer, but as disease progresses various symptoms arise, generally showing poorer prognosis with acute/chronic cholecystitis or focal biliary complications. 9 In our study, poorer prognosis was observed when there were abnormal results in the liver function tests, such as ALT, bilirubin, and ALP, in univariate analysis.
CEA is a typical tumor marker elevated not only in gallbladder cancer but also in colon cancer and other types of cancer. Chakravarty et al. 10 reported that serum CEA levels were independent prognostic factors that affect long-term survival regardless of T stage. Likewise, CEA was an independent prognostic factor in our study.
CA19-9 is a tumor marker frequently elevated in gallbladder cancer, especially associated with intra-epithelial dysplasia and adenocarcinoma. It has been reported to show significant association with other important prognostic factors such as a history of jaundice and lymph node metastasis. 11 Study to distinguish CA19-9 as a prognostic factor in gallbladder cancer has been insufficient, and in our study there was no association in univariate analysis.
The major principle in treatment of gallbladder cancer is surgical resection, with radiation therapy, chemotherapy, immunotherapy as optional choices, although effectiveness is meager. Recently, there has been a tendency towards determining surgical methods in gallbladder cancer according to T stage. 2, 12 Tis and T1a have shown complete remission with simple cholecystectomy alone. 13 In our study, all cases of Tis and T1a cancers were treated with simple cholecystectomy, and although comparison with radical cholecystectomy was unavailable, both groups showed 100%
survival rates at 5 and 10 years. In the case of stage T1b, the extent of resection is controversial. Lee et al. 14 reported that radical cholecystectomy had no benefit over simple cholecystectomy, whereas studies by Pilgrim et al. 15 and Abramson et al. 13 showed increased survival with radical resection, due to extraction of lymph node metastases and recurrence. There was no statistically significant difference according to surgical method in this study. There was no disadvantage to simple cholecystectomy, when compared with extended cholecystectomy according to median survival and 2-year survival rates in this study. As there were no deaths in the simple cholecystectomy subgroup, simple cholecystectomy in stage T1b could be regarded as curative resection.
There have also been disagreements on the extent of resection in stage T2. Ambramson et al. 13 calculated mean 5-year cancer -specific survival of 61.3% in simple cholecystectomy alone group, but 87.5% in radical cholecystectomy group. Pilgrim et al. 15 reported much higher 5 year survival rates in radical cholecystectomy (61% to 100%) when compared with simple cholecystectomy (19% to 50%). Zhu et al. 2 and Kang et al. 12 supported radical resection over simple resection, which showed higher 5-year survival rates in the T2 groups. On the contrary, Konstantinidis et al. 6 reported that there was no significant difference between radical and simple cholecystectomy. In addition, Kohya et al. 16 subdivided stage T2 patients into whether or not there was hepatic, biliary, lymphatic, venous, peri-neural or lymph node invasion, and proposed that radical resection was unnecessary in negative subgroups, whereas liver and/or biliary resection was needed when positive findings were present. Five year survival rates were confirmed to be higher in stage T2 radical resection subgroups in his study.
Stages T3 and T4 lead to poor prognosis, even after radical cholecystectomy. According to the French Surgical Association survey, 90% of patients with completed radical cholecystectomy expired within 12 months. 3 Likewise, this study also had no significant difference in surgical method in the T3 subgroups, with 5 year survival rates at 40.9% in the T3 and 0% in the T4 subgroups. On the other hand, Kondo et al. 17 reported T3, T4 with N1 patients were improved survival rate by lymph node dissection and with no detectable difference in 5-year survival rates between N0 (66%) and N1 (53%) patients.
In conclusion, CEA and T stage were independent prognostic factors significantly associated with patient survival in multivariate analysis. Although observation periods were short and number of cases was small, both simple and extended cholecystectomy showed similar survival rates in the T1b subgroups. Longer observation periods and more cases will be needed to confirm these conclusions.
